I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Szarek, Michael
224
results:
Online X
Search for persons
X
Format
Online (224)
Mediatypes
Articles (Online) (88)
Bookchapter (Online) (1)
OpenAccess-fulltext (135)
Sorted by: Relevance
Sorted by: Year
?
1
Time to clinical benefit with sotagliflozin in patients wit..:
Aggarwal, Rahul
;
Bhatt, Deepak L.
;
Szarek, Michael
...
European Journal of Heart Failure. 26 (2024) 4 - p. 1093-1095 , 2024
Link:
https://doi.org/10.1002/..
?
2
Alirocumab and cardiovascular outcomes according to sex and..:
Bittner, Vera A.
;
Schwartz, Gregory G.
;
Bhatt, Deepak L.
...
Journal of Clinical Lipidology. , 2024
Link:
https://doi.org/10.1016/..
?
3
Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:
Goodman, Shaun G
;
Steg, Philippe Gabriel
;
Szarek, Michael
...
European Heart Journal - Cardiovascular Pharmacotherapy. 10 (2024) 4 - p. 342-352 , 2024
Link:
https://doi.org/10.1093/..
?
4
Comparison of change in lipoprotein(a) mass and molar conce..:
Szarek, Michael
;
Reijnders, Esther
;
Steg, Ph Gabriel
...
European Journal of Preventive Cardiology. 31 (2024) 10 - p. e75-e78 , 2024
Link:
https://doi.org/10.1093/..
?
5
Sotagliflozin and Kidney Outcomes, Kidney Function, and Alb..:
Sridhar, Vikas S.
;
Bhatt, Deepak L.
;
Odutayo, Ayodele
...
Clinical Journal of the American Society of Nephrology. 19 (2024) 5 - p. 557-564 , 2024
Link:
https://doi.org/10.2215/..
?
6
How Generalizable Is The Soloist-whf Trial In 'Real World' ..:
Canonico, Mario Enrico
;
Hsia, Judith
;
Szarek, Michael
..
Journal of Cardiac Failure. 30 (2024) 1 - p. 228 , 2024
Link:
https://doi.org/10.1016/..
?
7
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reducti..:
Szarek, Michael
;
Bhatt, Deepak L.
;
Miller, Michael
...
Journal of the American College of Cardiology. 83 (2024) 16 - p. 1529-1539 , 2024
Link:
https://doi.org/10.1016/..
?
8
Efficacy and safety of SGLT2 inhibitors with and without gl..:
Apperloo, Ellen M
;
Neuen, Brendon L
;
Fletcher, Robert A
...
The Lancet Diabetes & Endocrinology. 12 (2024) 8 - p. 545-557 , 2024
Link:
https://doi.org/10.1016/..
?
9
Quantitative Benefit–Risk Evaluation of Rivaroxaban in Pati..:
Yuan, Zhong
;
Levitan, Bennett
;
Deng, Hsiaowei
...
Journal of the American Heart Association. 13 (2024) 8 - p. , 2024
Link:
https://doi.org/10.1161/..
?
10
Relating Lipoprotein(a) Concentrations to Cardiovascular Ev..:
Szarek, Michael
;
Reijnders, Esther
;
Jukema, J. Wouter
...
Circulation. 149 (2024) 3 - p. 192-203 , 2024
Link:
https://doi.org/10.1161/..
?
11
Effect of Sotagliflozin on Early Mortality and Heart Failur..:
Pitt, Bertram
;
Bhatt, Deepak L.
;
Szarek, Michael
...
JACC: Heart Failure. 11 (2023) 8 - p. 879-889 , 2023
Link:
https://doi.org/10.1016/..
?
12
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in..:
Aggarwal, Rahul
;
Bhatt, Deepak L.
;
Szarek, Michael
...
Journal of the American College of Cardiology. 82 (2023) 19 - p. 1842-1851 , 2023
Link:
https://doi.org/10.1016/..
?
13
Effect of sotagliflozin on albuminuria in patients with typ..:
Cherney, David Z. I.
;
Bhatt, Deepak L.
;
Szarek, Michael
...
Diabetes, Obesity and Metabolism. 25 (2023) 11 - p. 3410-3414 , 2023
Link:
https://doi.org/10.1111/..
?
14
Sotagliflozin, A Dual SGLT1 And SGLT2 Inhibitor, Reduces Fi..:
Pitt, Bertram
;
Szarek, Michael
;
Banks, Phillip
...
Journal of Cardiac Failure. 29 (2023) 4 - p. 683-684 , 2023
Link:
https://doi.org/10.1016/..
?
15
Rivaroxaban in patients with symptomatic peripheral artery ..:
Govsyeyev, Nicholas
;
Nehler, Mark
;
Conte, Michael S.
...
European Journal of Vascular and Endovascular Surgery. 65 (2023) 4 - p. e45-e46 , 2023
Link:
https://doi.org/10.1016/..
1-15